Encompass Health Overview
Latest ROE for Encompass Health: 23.91% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow23.91%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for EHC is 23.91%. That is above the Healthcare sector average of 20.86%. Investors often review this figure alongside Encompass Health's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, EHC currently prints 23.91% for ROE, while the sector average sits near 20.86%. That is roughly 14.6% above the sector mean. Large gaps often invite a closer look at Encompass Health's growth, margins, and balance sheet.
Return on Equity shows how effectively Encompass Health converts resources into returns. At 23.91%, EHC may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting EHC's ROE (23.91%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Encompass Health's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.
